Argent Capital Management LLC grew its holdings in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 16.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 45,812 shares of the company's stock after purchasing an additional 6,555 shares during the quarter. Argent Capital Management LLC owned about 0.25% of Addus HomeCare worth $5,743,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Wasatch Advisors LP lifted its stake in shares of Addus HomeCare by 11.8% during the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company's stock valued at $138,782,000 after acquiring an additional 110,010 shares during the period. Point72 Asset Management L.P. lifted its stake in shares of Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock valued at $86,598,000 after acquiring an additional 315,602 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company's stock valued at $82,930,000 after acquiring an additional 5,421 shares during the period. State Street Corp lifted its stake in shares of Addus HomeCare by 4.4% during the third quarter. State Street Corp now owns 663,610 shares of the company's stock valued at $88,280,000 after acquiring an additional 27,990 shares during the period. Finally, Principal Financial Group Inc. lifted its stake in shares of Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock valued at $67,293,000 after acquiring an additional 75,409 shares during the period. Institutional investors and hedge funds own 95.35% of the company's stock.
Insider Buying and Selling
In related news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the transaction, the chief executive officer now directly owns 79,397 shares of the company's stock, valued at $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 39,750 shares of company stock worth $4,930,750. 4.60% of the stock is owned by corporate insiders.
Addus HomeCare Price Performance
Shares of Addus HomeCare stock traded up $2.06 during trading hours on Thursday, hitting $133.33. The company's stock had a trading volume of 121,651 shares, compared to its average volume of 128,775. Addus HomeCare Co. has a 12 month low of $85.94 and a 12 month high of $136.12. The stock has a 50 day moving average of $125.07 and a 200 day moving average of $126.29. The company has a market capitalization of $2.42 billion, a PE ratio of 30.51, a price-to-earnings-growth ratio of 1.63 and a beta of 1.00.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare's quarterly revenue was up 7.1% on a year-over-year basis. During the same period last year, the company earned $1.03 earnings per share. Equities analysts expect that Addus HomeCare Co. will post 4.58 EPS for the current year.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on ADUS shares. Oppenheimer upped their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a research note on Monday, September 23rd. Citizens Jmp raised Addus HomeCare to a "strong-buy" rating in a research note on Monday, December 16th. Stephens increased their target price on Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a research note on Wednesday, November 6th. StockNews.com raised Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Wednesday, December 11th. Finally, Macquarie reissued an "outperform" rating and issued a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. One analyst has rated the stock with a sell rating, nine have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of $133.67.
View Our Latest Analysis on ADUS
Addus HomeCare Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Read More
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.